0001415889-24-013356.txt : 20240516 0001415889-24-013356.hdr.sgml : 20240516 20240516163048 ACCESSION NUMBER: 0001415889-24-013356 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240510 FILED AS OF DATE: 20240516 DATE AS OF CHANGE: 20240516 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BJERKHOLT ERIC CENTRAL INDEX KEY: 0001197350 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38981 FILM NUMBER: 24956075 MAIL ADDRESS: STREET 1: 132 PURDURE AVENUE CITY: KENGSINGTON STATE: CA ZIP: 94708 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mirum Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001759425 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 831281555 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 950 TOWER LANE, SUITE 1050 CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 650-667-4085 MAIL ADDRESS: STREET 1: 950 TOWER LANE, SUITE 1050 CITY: FOSTER CITY STATE: CA ZIP: 94404 4 1 form4-05162024_040533.xml X0508 4 2024-05-10 0001759425 Mirum Pharmaceuticals, Inc. MIRM 0001197350 BJERKHOLT ERIC C/O MIRUM PHARMACEUTICALS, INC. 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 false true false false CHIEF FINANCIAL OFFICER 0 Common Stock 2024-05-10 4 A 0 470 21.046 A 14470 D This Form 4 is being filed voluntarily to report the acquisition of 470 shares by the Reporting Person on May 10, 2024 pursuant to the Issuer's Employee Stock Purchase Plan. /s/ Judit Ryvkin, Attorney-in-Fact 2024-05-15